Ca-atra 10 - Tretinoin Softgel Capsule

Tretinoin, in its oral capsule form, is a retinoid derived from vitamin A that plays a distinct role in cancer treatment, separate from its topical use in skincare. It is specifically used to treat acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia, where it works by encouraging immature, abnormal white blood cells to mature into normal, functioning cells rather than continuing to multiply uncontrollably. This mechanism, known as differentiation therapy, represents an important treatment approach for APL and is often used in combination with other chemotherapy agents as part of a complete treatment regimen. Tretinoin capsules are typically used during the induction phase of treatment, helping to bring the disease into remission, and may also be used as part of maintenance therapy afterward. The medication is taken orally, with dosing carefully determined by a hematologist or oncologist based on the patient's specific diagnosis and treatment plan. Close monitoring, including regular blood tests, is an essential part of treatment to track the patient's response and guide any necessary adjustments. Many patients with APL achieve remission with Tretinoin-based treatment as part of a comprehensive care plan. Ongoing follow-up with a specialized healthcare team helps support long-term treatment success and monitor for any recurrence. As with all cancer treatments, Tretinoin capsules should be used strictly under the guidance of an experienced oncology healthcare provider.